Karnataka logs over 1,100 new COVID-19 cases, 6 deaths push toll to 12,403

As of March 16 evening, cumulatively 9,62,339 COVID-19 positive cases have been confirmed in the state, which includes 12,403 deaths and 9,40,489 discharges, the Health Department said in its bulletin.

PTI
March 16, 2021 / 09:30 PM IST

Karnataka has reported over 1,100 new COVID-19 cases and six related fatalities, taking the total number of infections to 9,62,339 and the death toll to 12,403, the Health department said on Tuesday.

The state had last reported over 1,000 cases on December 24, with 1,005 new cases.

Out of the 1,135 fresh cases reported on Tuesday, 710 were from Bengaluru Urban alone.

The day also saw 561 patients getting discharged after recovery.

As of March 16 evening, cumulatively 9,62,339 COVID-19 positive cases have been confirmed in the state, which includes 12,403 deaths and 9,40,489 discharges, the Health Department said in its bulletin.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

It said, out of 9,428 active cases, 9,299 patients are in isolation at designated hospitals and are stable, while 129 are in ICU.

Among the six deaths reported on Tuesday, three were from Bengaluru Urban and one each from Dharwad, Kalaburagi and Mysuru.

Among the districts where the new cases were reported, Bengaluru Urban accounted for 710, followed by Mysuru (58), Dakshina Kannada (50), Kalaburagi (46), Bengaluru Rural (38), Tumakuru and Udupi (32) followed by others.

Bengaluru Urban district tops the list of positive cases, with a total of 4,12,699, followed by Mysuru (54,549) and Ballari (39,426).

Among discharges too, Bengaluru Urban tops the list with 4,01,339, followed by Mysuru (53,249) and Ballari (38,713).

A total of over 1,99,21,424 samples have been tested so far, out of which 68,469 were tested on Tuesday alone, and 6,485 among them were rapid antigen tests.

Follow our full coverage of the coronavirus pandemic here.
PTI
TAGS: #coronavirus #Current Affairs #India #Karnataka
first published: Mar 16, 2021 09:29 pm